T&RBiofab

T&RBiofab is at the forefront of biotechnology research, dedicated to transforming lives through pioneering advancements in bioprinting, stem cells, and biomaterials. T&RBiofab has developed and produced their own 3D Bio-printing System for the creation of biodegradable scaffolds, Bio-ink, 3D Organoid Models, Cytotherapeutic Agents, and Artificial Organs

With a strong foundation in science and a product-oriented approach, T&RBiofab is committed to providing innovative biomedical solutions. Located at 237 Sangidaehak-ro, #542, Smart-Hub Industry-University Convergence Center, Gyeonggi-do, 15073, KR, and with additional locations at 107, Dosan-daero, 16th Floor SYH Tower, Seoul, Gangnam-gu 06035, KR, and 242 Pangyo-ro, 8F, Pangyo Digital Center Building C, Gyeonggi-do, Bundang-gu 13487, KR, T&RBiofab partners with key industry players to deliver patient-specific implants for reconstruction of damaged areas, cranio-maxillofacial meshes, and other advanced applications. T&RBiofab is also actively engaged in organ reconstruction and cell therapy, constantly pushing the boundaries of what's possible in the biomedical field.

T&RBiofab continues to expand its research and development efforts, focusing on creating artificial organs and innovative cell therapies. T&RBiofab is dedicated to improving patient outcomes and making a significant impact on global healthcare. We invite the manager of T&RBiofab to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work and reach a wider audience.